Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction

The Journal of Allergy and Clinical Immunology

Volumn 83, Issue 5, 1989, Pages 905-912

  Charlesworth, E N ^a   Kagey Sobotka, A ^a   Norman, P S ^a   Lichtenstein, Lawrence M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; HISTAMINE; PROSTAGLANDIN D2;

ADULT; BASOPHIL; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; ERYTHEMA; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MAST CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAGWEED ALLERGY; SKIN SENSITIVITY; SKIN TEST;

ADOLESCENT; ADULT; CELL COUNT; CELL MOVEMENT; CETIRIZINE; DOUBLE-BLIND METHOD; FEMALE; GRANULOCYTES; HISTAMINE RELEASE; HUMAN; HYDROXYZINE; HYPERSENSITIVITY, DELAYED; MALE; MIDDLE AGE; PROSTAGLANDIN D2; RANDOM ALLOCATION; SKIN TESTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024333843     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(89)90104-8     Document Type: Article

References (38)

1. 14-cetirizine in humans
2. The effect of tranquilizers on immediate skin wheal reaction
3. Immunologic therapy
4. Inhibitory effect of hydroxyzine on antigen-induced histamine release in vivo
5. Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares experimental dermatographism and cold-induced urticaria
6. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo
7. Basophil counting with a new staining method using alcian blue
8. Prostaglandin production by human peripheral blood in vitro
9. 2, and prostacyclin from human lung parenchyma
10. A novel doubleisotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics
11. Prolonged histamine release in cutaneous allergic reactions
12. Antihistamines
13. Action de la thymoxyethyl-diethyl-amine (939F) et des ethers phenoliques sur le choc anaphylactique du cobaye
14. Les antihistaminiques de synthese: essaid de chimotherapie des etats allergiques
15. The antihistamine properties of Benadryl, B-dimethyl-aminoethyl benzyldryl ether hydrochloride
16. Pharmacodynamic studies of a new antihistamine agent, N′-pridyl-N′-benzyl-N-dimethylethylene diamine HCl, pyribenzamine HCl. I. Effects on salivation, nictitating membrane, lachrymation, pupil and blood pressure
17. The relationship of in vitro and in vivo allergic histamine release: inhibition in primates by cAMP active agents
18. Evaluation of an antihistamine in ragweed hay fever
19. The anti-anaphylactic and histamine-releasing properties of the antihistamines: their effect on the mast cells
20. 2 antihistamines on allergic histamine release and its inhibition by histamine
21. The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine
22. Demonstration of inhibition of mediator release from mast cells by azatadine base: in vivo and in vitro evaluation
23. The effect of antihistamines on rat cutaneous early and late-phase reaction [Abstract]
24. An evaluation of the pharmacologic inhibition of the immediate and late cutaneous reaction to allergen
25. Effects of ketotifen and clemastine on passive transfer of reaginic reaction
26. Comparison of the suppressive effect of astemizole, terfenadine, and hydroxyzine on histamine-induced wheal and flares in humans
27. Effect in man of antiallergic drugs on the immediate and latephase cutaneous allergic reactions induced by anti-IgE
28. Local effects of synthetic leukotrienes in human skin
29. 2 and histamine during the immediate and the late-phase components of allergic cutaneous responses
30. 2 in rat and human skin
31. Skin eosinophilia in atopic patients
32. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis
33. Comparative studies on eosinophil chemotactic factors during leukocyte migration under agarose
34. The IgE-mediated release of eosinophil leukocyte chemotactic factor from human lung
35. The mediation of tissue eosinophilia in hypersensitivity reactions. V. Comparative studies of tissue eosinophilia in the skin lesions of local and systemic passive cutaneous anaphylactic reaction
36. Preferential human eosinophil chemotactic activity of the platelet-activating factor, 1-o-hexadecyl-2-acetyl-sn-gylceryl-3-phosphocholine (AGEPC)
37. Neutrophil chemotactic activity in antigen-induced late asthmatic reactions
38. Modulation of human neutrophil function by monohydroxyeicosatetraenoic acids